DSM-Firmenich AG (DSFIR) - Net Assets

Latest as of December 2025: €18.42 Billion EUR ≈ $21.54 Billion USD

Based on the latest financial reports, DSM-Firmenich AG (DSFIR) has net assets worth €18.42 Billion EUR (≈ $21.54 Billion USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€29.34 Billion ≈ $34.31 Billion USD) and total liabilities (€10.92 Billion ≈ $12.77 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check DSFIR intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets €18.42 Billion
% of Total Assets 62.78%
Annual Growth Rate 9.65%
5-Year Change 96.05%
10-Year Change 198.11%
Growth Volatility 32.14

DSM-Firmenich AG - Net Assets Trend (2013–2025)

This chart illustrates how DSM-Firmenich AG's net assets have evolved over time, based on quarterly financial data. See DSFIR days of operational coverage to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for DSM-Firmenich AG (2013–2025)

The table below shows the annual net assets of DSM-Firmenich AG from 2013 to 2025. For live valuation and market cap data, see DSM-Firmenich AG stock valuation.

Year Net Assets Change
2025-12-31 €18.42 Billion
≈ $21.54 Billion		 -18.83%
2024-12-31 €22.70 Billion
≈ $26.54 Billion		 -1.62%
2023-12-31 €23.07 Billion
≈ $26.97 Billion		 +112.72%
2022-12-31 €10.85 Billion
≈ $12.68 Billion		 +15.41%
2021-12-31 €9.40 Billion
≈ $10.99 Billion		 +25.51%
2020-12-31 €7.49 Billion
≈ $8.75 Billion		 -4.44%
2019-12-31 €7.83 Billion
≈ $9.16 Billion		 +0.26%
2018-12-31 €7.82 Billion
≈ $9.14 Billion		 +10.62%
2017-12-31 €7.07 Billion
≈ $8.26 Billion		 +14.32%
2016-12-31 €6.18 Billion
≈ $7.23 Billion		 +9.75%
2015-12-31 €5.63 Billion
≈ $6.58 Billion		 -5.14%
2014-12-31 €5.94 Billion
≈ $6.94 Billion		 -2.62%
2013-12-31 €6.10 Billion
≈ $7.13 Billion		 --

Equity Component Analysis

This analysis shows how different components contribute to DSM-Firmenich AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components €18.24 Billion 100.00%
Total Equity €18.24 Billion 100.00%

DSM-Firmenich AG Competitors by Market Cap

The table below lists competitors of DSM-Firmenich AG ranked by their market capitalization.

Company Market Cap
AIB Group PLC
IR:A5G
 $18.42 Billion
Yuanjie Semiconductor Technology Co. Ltd. A
SHG:688498
 $18.42 Billion
COCA COLA HBC AG ADRS
F:CCKC
 $18.44 Billion
EDP - Energias de Portugal S.A.
LS:EDP
 $18.47 Billion
Canon Inc
F:CNNA
 $18.41 Billion
Valterra Platinum Limited
JSE:VAL
 $18.41 Billion
Companhia de Saneamento Básico do Estado de São Paulo - SABESP
F:SAJA
 $18.41 Billion
Zhejiang Juhua Co Ltd
SHG:600160
 $18.41 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in DSM-Firmenich AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 22,511,000,000 to 18,244,000,000, a change of -4,267,000,000 (-19.0%).
  • Net loss of 1,081,000,000 reduced equity.
  • Dividend payments of 718,000,000 reduced retained earnings.
  • Share repurchases of 1,181,000,000 reduced equity.
  • Other comprehensive income decreased equity by 710,000,000.
  • Other factors decreased equity by 577,000,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €-1.08 Billion -5.93%
Dividends Paid €718.00 Million -3.94%
Share Repurchases €1.18 Billion -6.47%
Other Comprehensive Income €-710.00 Million -3.89%
Other Changes €-577.00 Million -3.16%
Total Change €- -18.96%

Book Value vs Market Value Analysis

This analysis compares DSM-Firmenich AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.04x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 2.16x to 1.04x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2013-12-31 €34.07 €73.46 x
2014-12-31 €33.01 €73.46 x
2015-12-31 €31.67 €73.46 x
2016-12-31 €34.56 €73.46 x
2017-12-31 €39.67 €73.46 x
2018-12-31 €44.13 €73.46 x
2019-12-31 €43.72 €73.46 x
2020-12-31 €42.91 €73.46 x
2021-12-31 €53.84 €73.46 x
2022-12-31 €61.99 €73.46 x
2023-12-31 €98.23 €73.46 x
2024-12-31 €85.08 €73.46 x
2025-12-31 €70.36 €73.46 x

Capital Efficiency Dashboard

This dashboard shows how efficiently DSM-Firmenich AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -5.93%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -11.97%
  • • Asset Turnover: 0.31x
  • • Equity Multiplier: 1.61x
  • Recent ROE (-5.93%) is below the historical average (7.09%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2013 4.27% 2.84% 0.74x 2.01x €-338.80 Million
2014 2.15% 1.74% 0.58x 2.12x €-449.30 Million
2015 3.14% 2.25% 0.66x 2.12x €-380.10 Million
2016 10.62% 8.14% 0.61x 2.13x €37.80 Million
2017 25.29% 20.40% 0.67x 1.84x €1.06 Billion
2018 13.74% 11.54% 0.68x 1.75x €290.80 Million
2019 8.73% 8.44% 0.59x 1.74x €-98.10 Million
2020 6.05% 5.53% 0.57x 1.94x €-291.90 Million
2021 9.36% 7.62% 0.71x 1.72x €-59.80 Million
2022 4.28% 5.48% 0.48x 1.62x €-614.30 Million
2023 9.33% 20.11% 0.31x 1.50x €-153.80 Million
2024 1.11% 1.95% 0.38x 1.50x €-2.00 Billion
2025 -5.93% -11.97% 0.31x 1.61x €-2.91 Billion

Industry Comparison

This section compares DSM-Firmenich AG's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $1,547,863,167
  • Average return on equity (ROE) among peers: -1.94%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
DSM-Firmenich AG (DSFIR) €18.42 Billion 4.27% 0.59x $18.41 Billion
Akzo Nobel NV (AKZA) $6.27 Billion 8.71% 1.60x $10.43 Billion
Avantium Holding BV (AVTX) $46.24 Million -49.37% 0.51x $191.32 Million
Corbion NV (CRBN) $742.60 Million 10.07% 0.91x $1.16 Billion
Holland Colours NV (HOLCO) $25.06 Million 11.66% 0.63x $81.30 Million
IMCD NV (IMCD) $729.18 Million 10.60% 1.27x $5.60 Billion
OCI NV (OCI) $1.48 Billion -3.30% 3.96x $761.80 Million

About DSM-Firmenich AG

AS:DSFIR Netherlands Specialty Chemicals
Market Cap
$21.78 Billion
€18.63 Billion EUR
Market Cap Rank
#1401 Global
#13 in Netherlands
Share Price
€73.46
Change (1 day)
-0.46%
52-Week Range
€55.42 - €95.76
All Time High
€123.65
Categories
Companies in Netherlands Specialty Chemicals
About

DSM-Firmenich AG provides nutrition, health, and beauty solutions in Switzerland, the Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. The company operates through four segments: Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health. The Perfumery & Beauty creates scents using natural, sy… Read more